000 | 01307 a2200313 4500 | ||
---|---|---|---|
005 | 20250518000947.0 | ||
264 | 0 | _c20191125 | |
008 | 201911s 0 0 eng d | ||
022 | _a1477-092X | ||
024 | 7 |
_a10.1177/1078155218800371 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBektas, Mert | |
245 | 0 | 0 |
_aA severe case of bevacizumab-induced thrombotic microangiopathy. _h[electronic resource] |
260 |
_bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _cOct 2019 |
||
300 |
_a1754-1757 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aBevacizumab _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aThrombotic Microangiopathies _xchemically induced |
700 | 1 | _aSamancı, Nilay S | |
700 | 1 | _aCokgezer, Simay | |
700 | 1 | _aKeskin, Dilek | |
700 | 1 | _aDemirelli, Fuat H | |
773 | 0 |
_tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _gvol. 25 _gno. 7 _gp. 1754-1757 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/1078155218800371 _zAvailable from publisher's website |
999 |
_c28872981 _d28872981 |